Header Logo

Connection

HSIAO-TUAN CHAO to Ranibizumab

Back to Details
This is a "connection" page, showing publications HSIAO-TUAN CHAO has written about Ranibizumab.
HSIAO-TUAN CHAO
Connection Strength
0.237
Ranibizumab
  1. Combined Therapy Versus Fortified Anti-VEGF Monotherapy in Type C Polypoidal Choroidal Vasculopathy: Long-Term Outcomes and Exploratory Biomarker Insights. Int J Mol Sci. 2026 Jan 26; 27(3).
    View in: PubMed
    Score: 0.237
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.